Held by 36 funds across 14 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Natco Pharma is held by 36 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹70 Cr. Among all holding funds, the manager with the highest conviction is DSP Nifty Smallcap250 Quality 50 Index Fund (DSP MF), which allocates a significant 1.78% of its entire portfolio to Natco Pharma.
In terms of category distribution, Index Fund funds hold the largest exposure by market value, representing 25 positions. Across different fund houses, Nippon India MF manages the largest aggregate stake, holding a combined value of ₹16 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
Portfolios as on: DSP MF May 2026 · Motilal Oswal MF Apr 2026 · Tata MF May 2026 · Nippon India MF Apr 2024 · Aditya Birla SL MF Apr 2026 · Kotak MF May 2026 · Mirae Asset MF May 2026 · LIC MF May 2026 · SBI MF May 2026 · ICICI Pru MF May 2026 · Franklin Templeton MF May 2026 · Groww MF Oct 2025 · Axis MF May 2026 · ITI MF May 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).